About This EventImmuneering (Nasdaq: IMRX) is celebrating a big win for pancreatic cancer patients: an extraordinary 94% chance of surviving past 6 months in recently announced results from a clinical ...

Both the S&P 500 and Nasdaq Composite indexes are hovering around all-time highs. Unsurprisingly, a euphoric narrative ...

E.ON is currently trading 0.09% lesser at EUR 16.13 on the XETRA.

One stock that managed to outmaneuver the various headwinds torturing the markets throughout the year, however, is data ...

Palantir's expansion into commercial markets has boosted its business. The stock has been on a tear since the start of 2024.

Meta's operating performance has been incredibly strong over the past year, thanks partly to its investments in AI, so its ...

Nvidia owns a 7% stake in CoreWeave, and made it possible for the young company to be the first to launch its latest GPUs. In ...

Although Alibaba stock looks reasonably priced, Amazon's lower business risk from the U.S.-China tensions gives it the edge ...

About This EventArtiva Biotherapeutics (Nasdaq: ARTV), visits the Nasdaq MarketSite in Times Square. Artiva is a clinical-stage biotechnology company whose mission is to develop effective, safe, and ...

With shares down 21% year to date, Tesla (NASDAQ: TSLA) is reeling from a combination of weakening electric vehicle (EV) ...

Palantir bulls point to this as a reason why the stock could reach a $1 trillion valuation by 2035. However, the bears have ...